In Class II, characterized by the most common heterozygous or homozygous F508del mutation affecting 85% of people with CF (PWCF) in Europe, the CFTR protein is misfolded and unable to reach the cell surface (De Boeck et al., 2014; Rafeeq and Murad, 2017). The gene discussed is CFTR; the disease is cystic fibrosis.